These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 9190938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
    Doucet C, Giron-Michel J, Canonica GW, Azzarone B.
    Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells.
    Murata T, Noguchi PD, Puri RK.
    J Biol Chem; 1995 Dec 22; 270(51):30829-36. PubMed ID: 8530527
    [Abstract] [Full Text] [Related]

  • 10. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
    Umeshita-Suyama R, Sugimoto R, Akaiwa M, Arima K, Yu B, Wada M, Kuwano M, Nakajima K, Hamasaki N, Izuhara K.
    Int Immunol; 2000 Nov 22; 12(11):1499-509. PubMed ID: 11058569
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A membrane-proximal region of the interleukin-2 receptor gamma c chain sufficient for Jak kinase activation and induction of proliferation in T cells.
    Nelson BH, Lord JD, Greenberg PD.
    Mol Cell Biol; 1996 Jan 22; 16(1):309-17. PubMed ID: 8524310
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells.
    Murata T, Puri RK.
    Cell Immunol; 1997 Jan 10; 175(1):33-40. PubMed ID: 9015186
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
    Malabarba MG, Rui H, Deutsch HH, Chung J, Kalthoff FS, Farrar WL, Kirken RA.
    Biochem J; 1996 Nov 01; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
    [Abstract] [Full Text] [Related]

  • 18. IL-4 and IL-13 activate the JAK2 tyrosine kinase and Stat6 in cultured human vascular endothelial cells through a common pathway that does not involve the gamma c chain.
    Palmer-Crocker RL, Hughes CC, Pober JS.
    J Clin Invest; 1996 Aug 01; 98(3):604-9. PubMed ID: 8698849
    [Abstract] [Full Text] [Related]

  • 19. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
    Murata T, Obiri NI, Puri RK.
    Int J Cancer; 1997 Jan 17; 70(2):230-40. PubMed ID: 9009165
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of IL-4 and IL-13 on CD44 expression in the Burkitt's lymphoma B cell line BL30/B95-8 and in Epstein-Barr virus (EBV) transformed human B cells: loss of IL-13 receptors on Burkitt's lymphoma B cells.
    Gee K, Kozlowski M, Kryworuchko M, Diaz-Mitoma F, Kumar A.
    Cell Immunol; 2001 Aug 01; 211(2):131-42. PubMed ID: 11591117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.